Renaissance Technologies’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.86M | Sell |
241,400
-154,500
| -39% | -$2.47M | 0.01% | 1678 |
|
|
2025
Q1 | $6.77M | Buy |
395,900
+315,000
| +389% | +$5.38M | 0.01% | 1234 |
|
|
2024
Q4 | $2M | Sell |
80,900
-108,100
| -57% | -$2.68M | ﹤0.01% | 2053 |
|
|
2024
Q3 | $5.39M | Sell |
189,000
-199,100
| -51% | -$5.68M | 0.01% | 1398 |
|
|
2024
Q2 | $10.2M | Buy |
388,100
+48,400
| +14% | +$1.28M | 0.02% | 906 |
|
|
2024
Q1 | $11M | Buy |
339,700
+321,400
| +1,756% | +$10.4M | 0.02% | 939 |
|
|
2023
Q4 | $771K | Sell |
18,300
-203,100
| -92% | -$8.56M | ﹤0.01% | 2561 |
|
|
2023
Q3 | $8.5M | Sell |
221,400
-246,400
| -53% | -$9.46M | 0.01% | 1015 |
|
|
2023
Q2 | $8.87M | Sell |
467,800
-24,312
| -5% | -$461K | 0.01% | 1093 |
|
|
2023
Q1 | $7.63M | Buy |
492,112
+148,012
| +43% | +$2.3M | 0.01% | 1234 |
|
|
2022
Q4 | $6.11M | Sell |
344,100
-8,400
| -2% | -$149K | 0.01% | 1393 |
|
|
2022
Q3 | $1.97M | Buy |
352,500
+19,900
| +6% | +$111K | ﹤0.01% | 2020 |
|
|
2022
Q2 | $1.3M | Buy |
332,600
+231,900
| +230% | +$904K | ﹤0.01% | 2530 |
|
|
2022
Q1 | $555K | Buy |
100,700
+83,100
| +472% | +$458K | ﹤0.01% | 3119 |
|
|
2021
Q4 | $150K | Buy |
+17,600
| New | +$150K | ﹤0.01% | 3606 |
|
|
2021
Q1 | – | Sell |
-5,600
| Closed | -$259K | – | 3492 |
|
|
2020
Q4 | $259K | Buy |
+5,600
| New | +$259K | ﹤0.01% | 3078 |
|
|
2020
Q3 | – | Sell |
-36,300
| Closed | -$884K | – | 3508 |
|
|
2020
Q2 | $884K | Buy |
+36,300
| New | +$884K | ﹤0.01% | 2601 |
|